Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · IEX Real-Time Price · USD
45.14
-1.97 (-4.18%)
At close: Jul 2, 2024, 4:00 PM
44.90
-0.24 (-0.53%)
After-hours: Jul 2, 2024, 6:30 PM EDT
Ionis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for IONS stock have an average target of 59.64, with a low estimate of 28 and a high estimate of 82. The average target predicts an increase of 32.12% from the current stock price of 45.14.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IONS stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 5 | 4 | 4 | 4 | 3 | 4 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 14 | 13 | 13 | 13 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $50 → $53 | Hold | Maintains | $50 → $53 | +17.41% | Jun 27, 2024 |
| Bernstein | Bernstein | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Jun 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +32.92% | Jun 3, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +32.92% | May 8, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $85 → $82 | Buy | Maintains | $85 → $82 | +81.66% | May 8, 2024 |
Financial Forecast
Revenue This Year
616.96M
from 787.65M
Decreased by -21.67%
Revenue Next Year
783.47M
from 616.96M
Increased by 26.99%
EPS This Year
-4.01
from -2.56
EPS Next Year
-3.25
from -4.01
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 794.9M | 1.2B | 1.7B | 2.3B | 2.9B |
| Avg | 617.0M | 783.5M | 1.1B | 1.4B | 1.8B |
| Low | 532.0M | 566.3M | 719.6M | 997.9M | 1.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.9% | 96.8% | 113.9% | 111.5% | 103.3% |
| Avg | -21.7% | 27.0% | 38.9% | 29.5% | 27.9% |
| Low | -32.5% | -8.2% | -8.2% | -8.3% | -20.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.34 | -0.49 | -0.05 | 1.06 | 3.36 |
| Avg | -4.01 | -3.25 | -2.17 | -0.41 | 1.22 |
| Low | -4.38 | -5.26 | -3.76 | -1.62 | -0.78 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.